[AMRX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
06-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -1.30%
YoY- -196.33%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 609,759 545,557 559,355 497,633 536,896 528,593 535,075 9.07%
PBT -7,655 2,180 -232,731 -9,921 -16,319 -2,043 34,824 -
Tax -1,797 4,570 7,350 -3,461 4,140 4,049 2,648 -
NP -5,858 -2,390 -120,808 -6,460 -6,377 -4,237 14,532 -
Tax Rate - -209.63% - - - - -7.60% -
Total Cost 615,617 547,947 680,163 504,093 543,273 532,830 520,543 11.79%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -0.96 -0.44 -21.60 -1.30 -1.19 -0.80 2.72 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.04 -0.02 -0.80 -0.04 -0.04 -0.03 0.10 -
EPS Diluted -0.04 -0.02 -0.80 -0.04 -0.04 -0.03 0.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.